Your browser doesn't support javascript.
loading
First-In-Human Pilot PET Immunoimaging Study of 64Cu-Anti-Carcinoembryonic Antigen Monoclonal Antibody (hT84.66-M5A) in Patients with Carcinoembryonic Antigen-Producing Cancers.
Wong, Jeffrey Y C; Yamauchi, David M; Adhikarla, Vikram; Simpson, Jennifer; Frankel, Paul H; Fong, Yuman; Melstrom, Kurt A; Chen, Yi-Jen; Salehian, Behrooz D; Woo, Yanghee; Dandapani, Savita V; Colcher, David M; Poku, Erasmus K; Yazaki, Paul J; Wu, Anna M; Shively, John E.
Afiliação
  • Wong JYC; Department of Radiation Oncology, City of Hope National Medical Center and the Beckman Research Institute, Duarte, California, USA.
  • Yamauchi DM; Department of Immunology and Theranostics, City of Hope National Medical Center and the Beckman Research Institute, Duarte, California, USA.
  • Adhikarla V; Department of Diagnostic Radiology, City of Hope National Medical Center and the Beckman Research Institute, Duarte, California, USA.
  • Simpson J; Department of Computational and Quantitative Medicine, City of Hope National Medical Center and the Beckman Research Institute, Duarte, California, USA.
  • Frankel PH; Department of Clinical Trials Office, City of Hope National Medical Center and the Beckman Research Institute, Duarte, California, USA.
  • Fong Y; Department of Computational and Quantitative Medicine, City of Hope National Medical Center and the Beckman Research Institute, Duarte, California, USA.
  • Melstrom KA; Department of Surgery, City of Hope National Medical Center and the Beckman Research Institute, Duarte, California, USA.
  • Chen YJ; Department of Surgery, City of Hope National Medical Center and the Beckman Research Institute, Duarte, California, USA.
  • Salehian BD; Department of Radiation Oncology, City of Hope National Medical Center and the Beckman Research Institute, Duarte, California, USA.
  • Woo Y; Department of Diabetes and Endocrinology, and City of Hope National Medical Center and the Beckman Research Institute, Duarte, California, USA.
  • Dandapani SV; Department of Surgery, City of Hope National Medical Center and the Beckman Research Institute, Duarte, California, USA.
  • Colcher DM; Department of Radiation Oncology, City of Hope National Medical Center and the Beckman Research Institute, Duarte, California, USA.
  • Poku EK; Department of Immunology and Theranostics, City of Hope National Medical Center and the Beckman Research Institute, Duarte, California, USA.
  • Yazaki PJ; Department of Radiopharmacy, City of Hope National Medical Center and the Beckman Research Institute, Duarte, California, USA.
  • Wu AM; Department of Immunology and Theranostics, City of Hope National Medical Center and the Beckman Research Institute, Duarte, California, USA.
  • Shively JE; Department of Immunology and Theranostics, City of Hope National Medical Center and the Beckman Research Institute, Duarte, California, USA.
Cancer Biother Radiopharm ; 38(1): 26-37, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36154291

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Neoplasias da Glândula Tireoide Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Biother Radiopharm Assunto da revista: FARMACIA / FARMACOLOGIA / NEOPLASIAS / TERAPEUTICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Neoplasias da Glândula Tireoide Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Biother Radiopharm Assunto da revista: FARMACIA / FARMACOLOGIA / NEOPLASIAS / TERAPEUTICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos